Skip to main content
[Preprint]. 2020 Jun 2:2020.05.28.20105692. [Version 1] doi: 10.1101/2020.05.28.20105692

Figure 5. Evaluation of the integrity of NAbs before and after pathogen inactivation treatment of plasma.

Figure 5.

Three convalescent plasma specimens from recovered COVID-19 patients were treated with amotosalen and UVA light for photochemical pathogen inactivation prior to administration to symptomatic COVID-19 patients. The impact on NAbs integrity was evaluated by neutralization PCR assay by comparing signals before (black) and after (gray) pathogen inactivation treatment. Error bars show standard deviations of three replicates.